BRPI0818354A2 - vacina preventiva do hiv baseada em anticorpos específicos para o hiv - Google Patents

vacina preventiva do hiv baseada em anticorpos específicos para o hiv

Info

Publication number
BRPI0818354A2
BRPI0818354A2 BRPI0818354A BRPI0818354A BRPI0818354A2 BR PI0818354 A2 BRPI0818354 A2 BR PI0818354A2 BR PI0818354 A BRPI0818354 A BR PI0818354A BR PI0818354 A BRPI0818354 A BR PI0818354A BR PI0818354 A2 BRPI0818354 A2 BR PI0818354A2
Authority
BR
Brazil
Prior art keywords
hiv
specific antibodies
vaccine based
preventive vaccine
hiv specific
Prior art date
Application number
BRPI0818354A
Other languages
English (en)
Portuguese (pt)
Inventor
Yu Filinova Elena
Original Assignee
Tech Integrale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tech Integrale Ltd filed Critical Tech Integrale Ltd
Publication of BRPI0818354A2 publication Critical patent/BRPI0818354A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0818354A 2007-10-09 2008-10-09 vacina preventiva do hiv baseada em anticorpos específicos para o hiv BRPI0818354A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97853607P 2007-10-09 2007-10-09
PCT/EP2008/008544 WO2009046984A1 (en) 2007-10-09 2008-10-09 Hiv preventive vaccine based on hiv specific antibodies

Publications (1)

Publication Number Publication Date
BRPI0818354A2 true BRPI0818354A2 (pt) 2017-05-16

Family

ID=40342551

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818354A BRPI0818354A2 (pt) 2007-10-09 2008-10-09 vacina preventiva do hiv baseada em anticorpos específicos para o hiv

Country Status (12)

Country Link
US (1) US20100215695A1 (enExample)
EP (1) EP2205736B1 (enExample)
JP (1) JP2010540674A (enExample)
KR (1) KR20100098597A (enExample)
CN (1) CN101970659A (enExample)
AU (1) AU2008309940B2 (enExample)
BR (1) BRPI0818354A2 (enExample)
CA (1) CA2701948A1 (enExample)
MX (1) MX2010003762A (enExample)
RU (1) RU2505604C2 (enExample)
WO (1) WO2009046984A1 (enExample)
ZA (1) ZA201002445B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2422618A1 (en) * 2010-08-27 2012-02-29 Technologie Integrale Ltd. Animal model for the evaluation of the efficacy of an HIV vaccine
CN102212133B (zh) * 2011-03-30 2013-01-16 中国医学科学院病原生物学研究所 人源HIV抗体的Fab片段及其编码基因与应用
CN102190726B (zh) * 2011-03-30 2013-03-27 中国医学科学院病原生物学研究所 一种人源HIV抗体的Fab片段及其编码基因与应用
CN104039350B (zh) * 2011-09-17 2019-07-05 源道隆（苏州）医学科技有限公司 任意三个或以上氨基酸残基构成的多肽表位及其相关抗体的诱导
US10660951B2 (en) 2012-09-17 2020-05-26 Zhiwei Allen Wu Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
EP2745845A1 (en) * 2012-12-19 2014-06-25 Centre Hospitalier Universitaire de Bordeaux A method for preventing or treating an HIV infection
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
RU2600031C2 (ru) * 2014-11-11 2016-10-20 Публичное акционерное общество "Фармсинтез" Лекарственная форма специфического иммунобиологического лекарственного средства для лечения и профилактики вич инфекции и способ ее получения
WO2017205694A1 (en) 2016-05-25 2017-11-30 University Of Maryland, Baltimore Methods of making active antibodies from biological fluids
CN106800603B (zh) * 2017-01-24 2020-07-28 中国食品药品检定研究院 检测抗hiv抗体的adcc活性的方法
EP3641806A4 (en) 2017-06-22 2021-06-23 University of Maryland, Baltimore Broadly neutralizing antibodies against hiv
IT202100004172A1 (it) * 2021-02-23 2022-08-23 Univ Degli Studi Milano Nuova composizione
IT202100004160A1 (it) * 2021-02-23 2022-08-23 Univ Degli Studi Milano Cellula ospite di leishmania

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2237065C2 (ru) * 2002-10-03 2004-09-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека
US20040109876A1 (en) * 2002-11-25 2004-06-10 Kureha Chemical Industry Co., Ltd. Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV

Also Published As

Publication number Publication date
EP2205736A1 (en) 2010-07-14
AU2008309940B2 (en) 2013-11-14
US20100215695A1 (en) 2010-08-26
RU2010116849A (ru) 2011-11-20
EP2205736B1 (en) 2014-04-02
CN101970659A (zh) 2011-02-09
MX2010003762A (es) 2010-09-10
JP2010540674A (ja) 2010-12-24
KR20100098597A (ko) 2010-09-08
AU2008309940A1 (en) 2009-04-16
ZA201002445B (en) 2011-03-30
CA2701948A1 (en) 2009-04-16
WO2009046984A1 (en) 2009-04-16
RU2505604C2 (ru) 2014-01-27

Similar Documents

Publication Publication Date Title
BRPI0818354A2 (pt) vacina preventiva do hiv baseada em anticorpos específicos para o hiv
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
ATE450271T1 (de) Impfstoff
DK2114993T3 (da) Vaccine
BRPI0818194A2 (pt) meio legível por computador
CR10571A (es) Vacuna virica recombinante
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
SE0850135L (sv) Häftapparat
BRPI0812818A2 (pt) Turbo-reator para aeronave
CR10705A (es) Anticuerpos para linfotoxina-alfa
DK2210105T3 (da) Mycobakterium-antigener
BRPI0817427A2 (pt) Anticorpo anti-bst2
EP2186607A4 (en) Stapler
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
BRPI0816926A2 (pt) Alça para embalagens com absorção térmica
BRPI0819448A2 (pt) Método para transações seguras
FR2921449B1 (fr) Rivet autoperforant
ES1071660U8 (es) Caldereta perfeccionada para sumidero.
ES1070237Y (es) "dispositivo antiseismos para la construccion"
BRPI0706249B1 (pt) reservatório-cobertura-piso para edificações.
ES1063735Y (es) Testero para persiana
ES1071784Y (es) Mecanismo practicable para hitos, postes o similares
ES1066061Y (es) Estuche para botellas
ES1066306Y (es) Pieza para corseteria

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]